These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 31043114)

  • 41. Lengthening of high-yield production levels of monoclonal antibody-producing Chinese hamster ovary cells by downregulation of breast cancer 1.
    Matsuyama R; Yamano N; Kawamura N; Omasa T
    J Biosci Bioeng; 2017 Mar; 123(3):382-389. PubMed ID: 27742176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid protein production from stable CHO cell pools using plasmid vector and the cumate gene-switch.
    Poulain A; Perret S; Malenfant F; Mullick A; Massie B; Durocher Y
    J Biotechnol; 2017 Aug; 255():16-27. PubMed ID: 28625678
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A proline metabolism selection system and its application to the engineering of lipid biosynthesis in Chinese hamster ovary cells.
    Budge JD; Roobol J; Singh G; Mozzanino T; Knight TJ; Povey J; Dean A; Turner SJ; Jaques CM; Young RJ; Racher AJ; Smales CM
    Metab Eng Commun; 2021 Dec; 13():e00179. PubMed ID: 34386349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A study of monoclonal antibody-producing CHO cell lines: what makes a stable high producer?
    Chusainow J; Yang YS; Yeo JH; Toh PC; Asvadi P; Wong NS; Yap MG
    Biotechnol Bioeng; 2009 Mar; 102(4):1182-96. PubMed ID: 18979540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of microRNA Targeted 3'UTRs to Repress DHFR Selection Marker Expression for Development of Recombinant Antibody Expressing CHO Cell Pools.
    Jossé L; Zhang L; Smales CM
    Biotechnol J; 2018 Oct; 13(10):e1800129. PubMed ID: 29981248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study of the mechanism for increased protein expression via transcription potency reduction of the selection marker.
    Yang B; Zhou J; Zhao H; Wang A; Lei Y; Xie Q; Xiong S
    Bioprocess Biosyst Eng; 2019 May; 42(5):799-806. PubMed ID: 30730009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A streamlined implementation of the glutamine synthetase-based protein expression system.
    Knox R; Nettleship JE; Chang VT; Hui ZK; Santos AM; Rahman N; Ho LP; Owens RJ; Davis SJ
    BMC Biotechnol; 2013 Sep; 13():74. PubMed ID: 24063773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteomic analysis of CHO cell lines producing high and low quantities of a recombinant antibody before and after selection with methotrexate.
    Hausmann R; Chudobová I; Spiegel H; Schillberg S
    J Biotechnol; 2018 Jan; 265():65-69. PubMed ID: 29137976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Molecular Basis of TnrA Control by Glutamine Synthetase in Bacillus subtilis.
    Hauf K; Kayumov A; Gloge F; Forchhammer K
    J Biol Chem; 2016 Feb; 291(7):3483-95. PubMed ID: 26635369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of Serpinb1 in Chinese hamster ovary cells increases recombinant IgG productivity.
    Lin N; Brooks J; Sealover N; George HJ; Kayser KJ
    J Biotechnol; 2015 Jan; 193():91-9. PubMed ID: 25444873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombinant Antibody Production in CHO and NS0 Cells: Differences and Similarities.
    Dhara VG; Naik HM; Majewska NI; Betenbaugh MJ
    BioDrugs; 2018 Dec; 32(6):571-584. PubMed ID: 30499081
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of expression of a humanized monoclonal antibody in mouse NSO myeloma cells and Chinese hamster ovary cells.
    Peakman TC; Worden J; Harris RH; Cooper H; Tite J; Page MJ; Gewert DR; Bartholemew M; Crowe JS; Brett S
    Hum Antibodies Hybridomas; 1994; 5(1-2):65-74. PubMed ID: 7532024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term culture of glutamine synthetase-transfected HepG2 cells in circulatory flow bioreactor for development of a bioartificial liver.
    Enosawa S; Miyashita T; Suzuki S; Li XK; Tsunoda M; Amemiya H; Yamanaka M; Hiramatsu S; Tanimura N; Omasa T; Suga K; Matsumura T
    Cell Transplant; 2000; 9(5):711-5. PubMed ID: 11144971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel bicistronic gene design couples stable cell line selection with a fucose switch in a designer CHO host to produce native and afucosylated glycoform antibodies.
    Roy G; Martin T; Barnes A; Wang J; Jimenez RB; Rice M; Li L; Feng H; Zhang S; Chaerkady R; Wu H; Marelli M; Hatton D; Zhu J; Bowen MA
    MAbs; 2018 Apr; 10(3):416-430. PubMed ID: 29400603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Repressing expression of difficult-to-express recombinant proteins during the selection process increases productivity of CHO stable pools.
    Maltais JS; Lord-Dufour S; Morasse A; Stuible M; Loignon M; Durocher Y
    Biotechnol Bioeng; 2023 Oct; 120(10):2840-2852. PubMed ID: 37232536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular Mechanisms of Glutamine Synthetase Mutations that Lead to Clinically Relevant Pathologies.
    Frieg B; Görg B; Homeyer N; Keitel V; Häussinger D; Gohlke H
    PLoS Comput Biol; 2016 Feb; 12(2):e1004693. PubMed ID: 26836257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
    Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High level expression of tissue inhibitor of metalloproteinases in Chinese hamster ovary cells using glutamine synthetase gene amplification.
    Cockett MI; Bebbington CR; Yarranton GT
    Biotechnology (N Y); 1990 Jul; 8(7):662-7. PubMed ID: 1369995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcriptome dynamics of transgene amplification in Chinese hamster ovary cells.
    Vishwanathan N; Le H; Jacob NM; Tsao YS; Ng SW; Loo B; Liu Z; Kantardjieff A; Hu WS
    Biotechnol Bioeng; 2014 Mar; 111(3):518-28. PubMed ID: 24108600
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Weak promoters to drive selection marker expression: Improvement of cell line development process for therapeutic protein production in CHO-K1 cells.
    Grindes L; Florimond C; Ribault S; Raymond C; Dieryck W; Joucla G; Corbin C
    J Biotechnol; 2023 Jun; 369():43-54. PubMed ID: 37149043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.